NOV INC (NOV) Stock Analyst Ratings
NYSE:NOV • US62955J1034
20.26 USD
+0.07 (+0.35%)
At close: Feb 27, 2026
20 USD
-0.26 (-1.28%)
After Hours: 2/27/2026, 8:23:06 PM
ChartMill assigns a Buy % Consensus number of 72% to NOV. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 18.25. This target is -9.91% below the current price.
- NOV was analyzed by 24 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about NOV.
- In the previous month the buy percentage consensus was at a similar level.
- NOV was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-11 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-09 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2026-02-09 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-02-06 | Stifel | Maintains | Buy -> Buy |
| 2026-02-04 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2026-01-07 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-07 | Susquehanna | Maintains | Positive -> Positive |
| 2025-12-18 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-12-17 | Barclays | Maintains | Underweight -> Underweight |
| 2025-12-11 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-12 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-11 | Barclays | Maintains | Underweight -> Underweight |
| 2025-11-05 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-10-30 | Barclays | Maintains | Underweight -> Underweight |
| 2025-10-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-29 | Stifel | Maintains | Buy -> Buy |
| 2025-10-08 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-08-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-07-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-30 | Susquehanna | Maintains | Positive -> Positive |
| 2025-07-30 | Stifel | Maintains | Buy -> Buy |
| 2025-07-30 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-07-30 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-07-16 | Stifel | Maintains | Buy -> Buy |
| 2025-07-01 | Susquehanna | Maintains | Positive -> Positive |
| 2025-06-05 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-05-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-01 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-05-01 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-04-30 | RBC Capital | Maintains | Outperform -> Outperform |
NOV INC / NOV FAQ
What is the price target for NOV stock?
24 analysts have analysed NOV and the average price target is 18.25 USD. This implies a price decrease of -9.91% is expected in the next year compared to the current price of 20.26.
How do analysts rate NOV INC (NOV)?
The consensus rating for NOV INC (NOV) is 71.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed NOV INC (NOV)?
The number of analysts covering NOV INC (NOV) is 24.